Unnati Pharmax

Pubergen 5000 IU Injection
Composition: Human Chorionic Gonadotropin (hCG) 5000 IU
International Trade Name: Pregnyl®

Pubergen 5000 IU is a high-quality Human Chorionic Gonadotropin (hCG) injection, formulated for subcutaneous or intramuscular administration. Manufactured in WHO-GMP certified facilities, Pubergen is supplied by trusted pharmaceutical exporters from India to support global fertility and reproductive health programs.

Human Chorionic Gonadotropin is a naturally occurring glycoprotein hormone that mimics the action of luteinizing hormone (LH), stimulating ovulation in women and testosterone production in men. Pubergen 5000 IU Injection is primarily indicated for the induction of ovulation and pregnancy in women with anovulatory infertility, as part of assisted reproductive therapy, and for the treatment of hypogonadism in males.

Pubergen hCG Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent potency, sterility, and therapeutic effectiveness. The injection is supplied in secure, sterile, export-grade packaging with complete regulatory documentation, making it suitable for fertility clinics, hospitals, government reproductive health programs, and international pharmaceutical distributors.

DERMAC-15 Gel
Composition: Azelaic Acid 15% Gel
International Trade Name: DERMAC®

DERMAC-15 is a high-quality topical Azelaic Acid 15% gel, formulated for the effective management of acne and hyperpigmentation. Manufactured in WHO-GMP certified facilities, DERMAC-15 Gel is supplied by trusted pharmaceutical exporters from India to support dermatology treatment programs worldwide.

Azelaic Acid is a naturally occurring dicarboxylic acid with antibacterial, anti-inflammatory, and keratolytic properties. DERMAC-15 Gel works by reducing the growth of acne-causing bacteria, normalizing keratinization, and diminishing pigmentation irregularities, helping to improve skin clarity and texture. It is primarily indicated for the topical treatment of mild to moderate acne vulgaris, post-inflammatory hyperpigmentation, and rosacea.

DERMAC-15 Azelaic Acid Gel is manufactured under stringent GMP quality standards, ensuring consistent efficacy, safety, and long-term stability. The gel is supplied in secure, hygienic, and export-grade packaging with complete regulatory documentation, making it suitable for dermatology clinics, hospitals, pharmacies, government health programs, and international pharmaceutical distributors.

ASTHLIN INH Inhaler
Composition: Salbutamol Inhalation IP 100 mcg/dose
International Trade Name: Ventolin® / Salbutamol Inhaler

ASTHLIN INH is a high-quality Salbutamol 100 mcg/dose metered-dose inhaler, a reliable generic equivalent of the internationally recognized bronchodilator marketed under the brand name Ventolin®. Manufactured in WHO-GMP certified facilities, ASTHLIN INH Inhaler is supplied by trusted pharmaceutical exporters from India to support global respiratory treatment programs, particularly for asthma and chronic obstructive pulmonary disease (COPD) management.

Salbutamol is a selective β2-adrenergic receptor agonist that works by relaxing bronchial smooth muscles, leading to rapid bronchodilation and relief from wheezing, shortness of breath, and other respiratory symptoms. ASTHLIN INH is primarily indicated for the relief and prevention of bronchospasm in patients with asthma, exercise-induced bronchospasm, and COPD.

ASTHLIN INH Salbutamol Inhaler is manufactured under stringent GMP and inhalation device quality standards, ensuring consistent efficacy, safety, and long-term stability. The inhaler is supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, clinics, retail pharmacies, government healthcare programs, and international pharmaceutical distributors.

Enclex 40 mg Injection
Composition: Enoxaparin Sodium Injection 40 mg
International Trade Name: Clexane®

Enclex is a high-quality Enoxaparin Sodium 40 mg injection, a low molecular weight heparin (LMWH) used for the prevention and treatment of thromboembolic disorders. It is a reliable generic equivalent of the internationally recognized anticoagulant brand Clexane®. Manufactured in WHO-GMP certified facilities, Enclex Injection is supplied by trusted pharmaceutical exporters from India to support global cardiovascular, surgical, and critical care treatment programs.

Enoxaparin works by inhibiting clotting factors, particularly Factor Xa, thereby preventing the formation of harmful blood clots. Enclex 40 mg Injection is primarily indicated for the prophylaxis and treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), unstable angina, myocardial infarction, and for thromboprophylaxis in patients undergoing major surgeries or those with prolonged immobilization.

Enclex Enoxaparin Injection is manufactured under stringent GMP and sterile injectable quality standards, ensuring consistent potency, safety, and long-term stability. The injection is supplied in secure, prefilled syringe or vial presentations with complete regulatory documentation, making it suitable for hospitals, cardiac care units, orthopedic centers, government healthcare programs, and international pharmaceutical distributors.

Neukine 300 Filgrastim Injection (300 mcg)
Composition: Filgrastim Injection 300 micrograms
International Trade Reference: Nivestim®, Tevagrastim®

Neukine 300 is a high-quality Filgrastim 300 mcg injection, a biosimilar equivalent of internationally recognized recombinant human granulocyte colony-stimulating factor (G-CSF) products such as Nivestim® and Tevagrastim®. Manufactured in WHO-GMP certified facilities, Neukine Injection is supplied by trusted pharmaceutical exporters from India to support global oncology and hematology care programs.

Filgrastim is a recombinant form of human G-CSF that stimulates the bone marrow to produce and release neutrophils into the bloodstream. Neukine 300 Filgrastim Injection is primarily indicated for the prevention and treatment of chemotherapy-induced neutropenia, reduction of the duration of severe neutropenia, and lowering the risk of infection in cancer patients receiving myelosuppressive chemotherapy. It is also used in bone marrow transplantation, severe chronic neutropenia, and for mobilization of peripheral blood progenitor cells (PBPCs).

Neukine 300 Filgrastim Injection is manufactured under stringent GMP and biologics quality standards to ensure consistent efficacy, safety, and stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology centers, hematology units, tertiary care hospitals, government healthcare programs, and international pharmaceutical distributors.

Rexigo 120 mg Tablets
Composition: Relugolix Tablets 120 mg
International Trade Name: Orgovyx®

Rexigo is a high-quality Relugolix 120 mg tablet, an orally active, non-peptide gonadotropin-releasing hormone (GnRH) receptor antagonist used primarily in the management of advanced prostate cancer. It is a reliable generic equivalent of the internationally recognized brand Orgovyx®. Manufactured in WHO-GMP certified facilities, Rexigo Tablets are supplied by trusted pharmaceutical exporters from India to support global oncology and hormone therapy treatment programs.

Relugolix works by directly inhibiting GnRH receptors in the pituitary gland, leading to rapid suppression of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and consequently reducing testosterone levels. This mechanism helps slow the growth and progression of hormone-sensitive prostate cancer. Rexigo 120 mg Tablets are primarily indicated for the treatment of adult patients with advanced prostate cancer requiring androgen deprivation therapy (ADT).

Rexigo Relugolix Tablets are manufactured under stringent GMP quality standards, ensuring consistent potency, safety, and long-term stability. The tablets are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for oncology clinics, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

DARBITOP 40 Injection
Composition: Darbepoetin Alfa Injection 40 mcg/0.40 ml
International Trade Name: Aranesp®

DARBITOP 40 is a high-quality Darbepoetin Alfa 40 mcg injection, a reliable biosimilar equivalent of the internationally recognized erythropoiesis-stimulating agent (ESA) marketed under the brand name Aranesp®. Manufactured in WHO-GMP certified facilities, DARBITOP Injection is supplied by trusted pharmaceutical exporters from India to support global anemia management programs, particularly in patients with chronic kidney disease and those undergoing chemotherapy.

Darbepoetin Alfa is a long-acting recombinant human erythropoietin analog that stimulates red blood cell production by acting on erythroid progenitor cells in the bone marrow. DARBITOP 40 Injection is primarily indicated for the treatment of anemia associated with chronic renal failure and chemotherapy-induced anemia in cancer patients. Its prolonged half-life allows for reduced dosing frequency while maintaining stable hemoglobin levels.

DARBITOP 40 Darbepoetin Alfa Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for dialysis centers, oncology units, tertiary care hospitals, government healthcare programs, and international pharmaceutical distributors.

Cresp 60 Injection
Composition: Darbepoetin Alfa Injection 60 mcg
International Trade Name: Aranesp®

Cresp 60 is a high-quality Darbepoetin Alfa 60 mcg injection, a reliable biosimilar equivalent of the internationally recognized erythropoiesis-stimulating agent (ESA) marketed under the brand name Aranesp®. Manufactured in WHO-GMP certified facilities, Cresp Injection is supplied by trusted pharmaceutical exporters from India to support global anemia management programs, particularly in patients with chronic kidney disease and those undergoing chemotherapy.

Darbepoetin Alfa is a long-acting recombinant human erythropoietin analog that stimulates red blood cell production by acting on erythroid progenitor cells in the bone marrow. Cresp 60 Injection is primarily indicated for the treatment of anemia associated with chronic renal failure and chemotherapy-induced anemia in cancer patients. Its extended half-life allows for less frequent dosing while maintaining effective hemoglobin control.

Cresp 60 Darbepoetin Alfa Injection is manufactured under stringent GMP and biologics quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for dialysis centers, oncology units, tertiary care hospitals, government healthcare programs, and international pharmaceutical distributors.

Globucel 10 Injection
Composition: Human Normal Immunoglobulin for Intravenous Use IP 10% Solution
International Trade Name: IVIG

Globucel 10 is a high-quality Human Immunoglobulin 10% solution formulated for intravenous administration, designed to provide passive immunity and immunomodulatory effects in patients with immune deficiencies and selected autoimmune or inflammatory conditions. Manufactured in WHO-GMP certified facilities, Globucel 10 is supplied by trusted pharmaceutical exporters from India to support global immunotherapy and critical care treatment programs.

Human normal immunoglobulin is a purified preparation of polyvalent IgG antibodies derived from healthy human plasma. It works by supplementing deficient antibodies, neutralizing pathogens, and modulating abnormal immune responses. Globucel 10 is primarily indicated for use in primary and secondary immunodeficiency states, immune thrombocytopenic purpura (ITP), Kawasaki disease, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), and other immune-mediated disorders, as per approved clinical guidelines.

Globucel 10 Human Immunoglobulin Injection is manufactured under stringent GMP and plasma fractionation quality standards, ensuring consistent purity, safety, viral inactivation, and long-term stability. The solution is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for tertiary care hospitals, specialty clinics, government healthcare programs, and international pharmaceutical distributors.

EZEDOC 10 Tablets
Composition: Ezetimibe Tablets IP 10 mg
International Trade Name: Zetia®

EZEDOC 10 is a high-quality Ezetimibe 10 mg tablet, a reliable generic equivalent of the internationally recognized cholesterol-lowering agent marketed under the brand name Zetia®. Manufactured in WHO-GMP certified facilities, EZEDOC 10 Tablets are supplied by trusted pharmaceutical exporters from India to support global cardiovascular and lipid management programs.

Ezetimibe is a selective cholesterol absorption inhibitor that works by blocking the absorption of cholesterol at the brush border of the small intestine, leading to decreased total cholesterol, LDL-C, and Apo B levels. EZEDOC 10 Tablets are primarily indicated for the treatment of hypercholesterolemia, mixed dyslipidemia, and for patients who require additional LDL-C reduction despite dietary modification and other lipid-lowering therapies. They can be used alone or in combination with statins for optimal lipid control.

EZEDOC 10 Ezetimibe Tablets are manufactured under stringent GMP quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, retail pharmacies, government healthcare programs, and international pharmaceutical distributors.

DEE-X-1 Capsules
Composition: Doxycycline Hydrochloride Capsules IP 100 mg
International Trade Name: Vibramycin® / Doryx®

DEE-X-1 is a high-quality Doxycycline Hydrochloride 100 mg capsule, a reliable generic equivalent of the internationally recognized broad-spectrum antibiotic marketed under the brand names Vibramycin® and Doryx®. Manufactured in WHO-GMP certified facilities, DEE-X-1 Capsules are supplied by trusted pharmaceutical exporters from India to support global antibacterial treatment programs across multiple therapeutic areas.

Doxycycline Hydrochloride is a tetracycline-class antibiotic that works by inhibiting bacterial protein synthesis, thereby preventing the growth and replication of susceptible microorganisms. DEE-X-1 Capsules are primarily indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, sexually transmitted infections, acne, malaria prophylaxis, and other infections caused by susceptible Gram-positive and Gram-negative bacteria.

DEE-X-1 Doxycycline Hydrochloride Capsules are manufactured under stringent GMP quality standards, ensuring consistent efficacy, safety, and long-term stability. The capsules are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, retail pharmacies, government healthcare programs, and international pharmaceutical distributors.

Naproheal 250 mg Tablets
Composition: Naproxen Tablets IP 250 mg
International Trade Name: Naprosyn®

Naproheal 250 is a high-quality Naproxen 250 mg tablet, a widely used non-steroidal anti-inflammatory drug (NSAID) formulated to provide effective relief from pain, inflammation, and fever. Manufactured in WHO-GMP certified facilities, Naproheal Tablets are supplied by trusted pharmaceutical exporters from India to support global pain management and anti-inflammatory treatment programs.

Naproxen works by inhibiting the production of prostaglandins, which are responsible for pain, inflammation, and swelling. Naproheal 250 mg Tablets are primarily indicated for the management of mild to moderate pain, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, musculoskeletal disorders, dysmenorrhea, and acute gout attacks.

Naproheal 250 Naproxen Tablets are manufactured under stringent GMP quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, retail pharmacies, government healthcare programs, and international pharmaceutical distributors.

U.V.A.CEF 200 Tablets
Composition: Cefpodoxime Proxetil Tablets IP 200 mg
International Trade Name: Orelox® / Vantin®

U.V.A.CEF 200 is a high-quality Cefpodoxime Proxetil 200 mg tablet, a reliable generic equivalent of the internationally recognized third-generation cephalosporin antibiotic marketed under the brand names Orelox® and Vantin®. Manufactured in WHO-GMP certified facilities, U.V.A.CEF 200 Tablets are supplied by trusted pharmaceutical exporters from India to support global antibacterial treatment programs, particularly for the management of bacterial infections caused by susceptible organisms.

Cefpodoxime Proxetil is a broad-spectrum oral cephalosporin that works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. U.V.A.CEF 200 Tablets are primarily indicated for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, pharyngitis, tonsillitis, otitis media, and other infections caused by susceptible Gram-positive and Gram-negative bacteria.

U.V.A.CEF 200 Cefpodoxime Proxetil Tablets are manufactured under stringent GMP quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, retail pharmacies, government healthcare programs, and international pharmaceutical distributors.

ESOHEAL 40 Tablets
Composition: Esomeprazole Gastro-Resistant Tablets IP 40 mg
International Trade Name: Nexium®

ESOHEAL 40 is a high-quality Esomeprazole 40 mg gastro-resistant tablet, a reliable generic equivalent of the internationally recognized proton pump inhibitor (PPI) marketed under the brand name Nexium®. Manufactured in WHO-GMP certified facilities, ESOHEAL 40 Tablets are supplied by trusted pharmaceutical exporters from India to support global gastroenterology treatment programs, particularly for acid-related disorders.

Esomeprazole is a selective proton pump inhibitor that works by irreversibly inhibiting the H⁺/K⁺-ATPase enzyme system in gastric parietal cells, thereby reducing gastric acid secretion. ESOHEAL 40 Gastro-Resistant Tablets are primarily indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger–Ellison syndrome, peptic ulcer disease, and other hypersecretory conditions. The gastro-resistant formulation ensures protection of the active ingredient from stomach acid, allowing effective absorption in the intestine.

ESOHEAL 40 Esomeprazole Tablets are manufactured under stringent GMP quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, retail pharmacies, government healthcare programs, and international pharmaceutical distributors.

Depo-Provera Injection
Composition: Medroxyprogesterone Acetate Injection 150 mg
International Trade Name: Depo-Provera®

Depo-Provera is a high-quality Medroxyprogesterone Acetate 150 mg injection, a reliable generic equivalent of the internationally recognized long-acting contraceptive and hormone therapy agent marketed under the brand name Depo-Provera®. Manufactured in WHO-GMP certified facilities, Depo-Provera Injection is supplied by trusted pharmaceutical exporters from India to support global reproductive health and family planning programs.

Medroxyprogesterone Acetate is a synthetic progestogen that works by inhibiting ovulation, thickening cervical mucus, and altering the endometrium to prevent pregnancy. Depo-Provera 150 mg Injection is primarily indicated for long-term contraception in women, management of menstrual disorders, and treatment of endometriosis. Its depot formulation allows for slow release and provides effective contraception for up to 3 months per injection.

Depo-Provera Medroxyprogesterone Acetate Injection is manufactured under stringent GMP and sterile injectable quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, tamper-proof, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for hospitals, clinics, government family planning programs, and international pharmaceutical distributors.

KENZ Ketoconazole Tablets IP 200 mg
Composition: Ketoconazole Tablets IP 200 mg
International Trade Name: Nizoral®

KENZ is a high-quality Ketoconazole 200 mg tablet, a reliable generic equivalent of the internationally recognized broad-spectrum antifungal agent marketed under the brand name Nizoral®. Manufactured in WHO-GMP certified facilities, KENZ tablets are supplied by trusted pharmaceutical exporters from India to support global antifungal treatment programs for a wide range of fungal and yeast infections.

Ketoconazole is a potent imidazole antifungal agent that works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane integrity and leading to fungal cell death. KENZ Ketoconazole Tablets IP 200 mg are primarily indicated for the treatment of systemic and superficial fungal infections, including candidiasis, dermatophytosis, blastomycosis, histoplasmosis, coccidioidomycosis, and other susceptible fungal conditions, particularly in cases where alternative antifungal therapies are not suitable.

KENZ Ketoconazole Tablets are manufactured under stringent GMP quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, retail pharmacies, government healthcare programs, and international pharmaceutical distributors.

Canesten V6 Vaginal Tablets / Cream
Composition: Clotrimazole
International Trade Name: Canesten®

Canesten V6 is a high-quality Clotrimazole vaginal formulation designed for the effective treatment of fungal infections of the vagina. It is a trusted antifungal medicine widely used for the management of vulvovaginal candidiasis (yeast infections). Manufactured under strict pharmaceutical quality standards, Canesten Vaginal products are supplied by reputed manufacturers to support women’s health and gynecological care worldwide.

Clotrimazole is a broad-spectrum imidazole antifungal agent that works by inhibiting the growth of fungi through disruption of the fungal cell membrane. Canesten V6 is specifically formulated to relieve symptoms such as itching, burning, redness, abnormal discharge, and irritation associated with vaginal yeast infections. It provides targeted local action, ensuring rapid symptom relief and effective eradication of the causative organisms.

Canesten V6 Clotrimazole Vaginal formulations are produced under stringent GMP standards to ensure consistent quality, safety, and therapeutic effectiveness. The product is supplied in hygienic, patient-friendly, and export-grade packaging with complete regulatory documentation, making it suitable for hospitals, gynecology clinics, retail pharmacies, women’s healthcare programs, and international pharmaceutical distributors.

Tigebax 50 mg Injection
Composition: Tigecycline Injection 50 mg
International Trade Name: Tygacil®

Tigebax is a high-quality Tigecycline 50 mg injection, a broad-spectrum glycylcycline antibiotic formulated for intravenous use in the treatment of serious and complicated bacterial infections. It is a reliable generic equivalent of the internationally recognized brand Tygacil®. Manufactured in WHO-GMP certified facilities, Tigebax Injection is supplied by trusted pharmaceutical exporters from India to support global hospital-based anti-infective treatment programs.

Tigecycline exhibits potent activity against a wide range of Gram-positive, Gram-negative, anaerobic, and multidrug-resistant organisms. It works by inhibiting bacterial protein synthesis, thereby preventing bacterial growth and multiplication. Tigebax 50 mg Injection is primarily indicated for the treatment of complicated skin and skin structure infections, complicated intra-abdominal infections, and community-acquired bacterial pneumonia caused by susceptible organisms, especially in cases where resistance to conventional antibiotics is a concern.

Tigebax Tigecycline Injection is manufactured under stringent GMP quality standards to ensure consistent potency, sterility, safety, and long-term stability. The product is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for tertiary care hospitals, intensive care units, government healthcare programs, and international pharmaceutical distributors.

Mebendazole 500mg Tablets
Composition: Mebendazole Tablets 500mg
International Trade Name: Mebentel®

Mebentel 500 is a high-quality Mebendazole 500mg Tablet, a broad-spectrum anthelmintic formulation widely used for the effective treatment of intestinal parasitic worm infections. Manufactured in WHO-GMP certified facilities, Mebentel Tablets are supplied by trusted pharmaceutical exporters from India to support large-scale deworming programs, hospital supply chains, and global public health initiatives.

Mebendazole is a well-established benzimidazole anthelmintic that works by inhibiting glucose uptake and microtubule formation in parasitic worms, leading to their immobilization and death. Mebentel 500mg Tablets are primarily indicated for the treatment of common helminth infections such as ascariasis (roundworm), trichuriasis (whipworm), hookworm infections, enterobiasis (pinworm), and mixed intestinal worm infestations, in both adults and pediatric populations as per clinical guidelines.

Mebentazole 500mg tablets, Mebentel tablets, deworming medicine, anthelmintic tablets, intestinal worm infection treatment, antiparasitic drug exporter India, WHO-GMP pharmaceutical manufacturer India, and bulk supply of deworming tablets.

Mebentel 500 Tablets are manufactured under stringent GMP and pharmaceutical quality standards, ensuring consistent potency, safety, and stability throughout their shelf life. The tablets are supplied in export-grade packaging with complete regulatory and quality documentation, making them suitable for hospitals, clinics, government deworming programs, NGOs, tender supplies, and international pharmaceutical distributors.

Coly-Monas 4.5 Injection
Composition: Colistimethate Sodium for Injection IP 4.5 MIU
International Trade Name: Coly-Mycin® / Colistin®

Coly-Monas 4.5 is a high-quality Colistimethate Sodium 4.5 MIU injection, a reliable generic equivalent of the internationally recognized polymyxin antibiotic marketed under various global brand names. Manufactured in WHO-GMP certified facilities, Coly-Monas Injection is supplied by trusted pharmaceutical exporters from India to support advanced global antibacterial treatment programs, particularly for multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacterial infections.

Colistimethate Sodium is a prodrug of colistin, a potent bactericidal antibiotic that acts by disrupting the bacterial cell membrane, leading to cell death. Coly-Monas 4.5 Injection is primarily indicated for the treatment of severe infections caused by susceptible Gram-negative organisms, including Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae, especially in cases where alternative antibiotics are ineffective. It is widely used in intensive care units for life-threatening infections such as ventilator-associated pneumonia, bloodstream infections, and complicated urinary tract infections.

Coly-Monas 4.5 Colistimethate Sodium Injection is manufactured under stringent GMP and sterile injectable quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, moisture-protected, export-grade packaging with complete regulatory documentation, making it suitable for critical care units, tertiary care hospitals, government healthcare programs, and international pharmaceutical distributors.

Zavicefta Injection
Composition: Ceftazidime 2 g + Avibactam 0.5 g Powder for Concentrate for Solution for Infusion
International Trade Name: Zavicefta® / Avycaz®

Zavicefta is a high-quality combination injectable antibiotic containing Ceftazidime 2 g and Avibactam 0.5 g, formulated as a reliable generic equivalent of the internationally recognized β-lactam/β-lactamase inhibitor combination marketed under the brand name Avycaz®. Manufactured in WHO-GMP certified facilities, Zavicefta is supplied by trusted pharmaceutical exporters from India to support advanced global antibacterial treatment programs, particularly for multidrug-resistant (MDR) Gram-negative bacterial infections.

Ceftazidime is a third-generation cephalosporin antibiotic with strong activity against Gram-negative pathogens, while Avibactam is a non-β-lactam β-lactamase inhibitor that protects ceftazidime from enzymatic degradation by resistant bacteria. This synergistic combination restores antibacterial activity against organisms producing extended-spectrum β-lactamases (ESBLs), AmpC, and certain carbapenemases. Zavicefta Injection is primarily indicated for the treatment of complicated intra-abdominal infections, complicated urinary tract infections, hospital-acquired pneumonia, ventilator-associated pneumonia, and other serious infections caused by susceptible organisms.

Zavicefta Ceftazidime + Avibactam Injection is manufactured under stringent GMP and sterile injectable quality standards, ensuring consistent efficacy, safety, and long-term stability. The product is supplied in secure, moisture-protected, export-grade packaging with complete regulatory documentation, making it suitable for intensive care units, tertiary care hospitals, government healthcare programs, and international pharmaceutical distributors.

Taffic Tablets
Composition: Tranexamic Acid Tablets IP 500 mg International Trade Name: Cyklokapron®

Taffic is a high-quality Tranexamic Acid tablet, a reliable generic equivalent of the internationally recognized antifibrinolytic agent marketed under the brand name Cyklokapron®. Manufactured in WHO-GMP certified facilities, Taffic Tablets are supplied by trusted pharmaceutical exporters from India to support global bleeding management and hemostatic treatment programs across multiple clinical specialties.

Tranexamic Acid is a synthetic lysine analogue that works by inhibiting fibrinolysis through blocking the activation of plasminogen to plasmin, thereby preventing the breakdown of blood clots. Taffic Tablets are primarily indicated for the treatment and prevention of excessive bleeding associated with menorrhagia, dental procedures in hemophilia patients, trauma, surgical interventions, epistaxis, and other hemorrhagic conditions.

Taffic Tranexamic Acid Tablets are manufactured under stringent GMP quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, retail pharmacies, government healthcare programs, and international pharmaceutical distributors.

FANIT-40 Tablets
Composition: Famotidine Tablets 40 mg
International Trade Name: Pepcid®

FANIT-40 is a high-quality Famotidine 40 mg tablet, formulated to provide effective management of acid-related gastrointestinal disorders. Manufactured in WHO-GMP certified facilities, FANIT-40 Tablets are supplied by trusted pharmaceutical exporters from India to support global gastroenterology treatment programs.

Famotidine is a selective histamine H2 receptor antagonist that works by reducing gastric acid secretion, providing relief from symptoms such as heartburn, acid reflux, and stomach discomfort. FANIT-40 Tablets are primarily indicated for the treatment and prevention of gastroesophageal reflux disease (GERD), peptic ulcers, Zollinger-Ellison syndrome, and other conditions associated with hyperacidity.

FANIT-40 Famotidine Tablets are manufactured under stringent GMP quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, retail pharmacies, government healthcare programs, and international pharmaceutical distributors.

Lanzol Junior 30 mg Orally Disintegrating Tablets
Composition: Lansoprazole Orally Disintegrating Tablets IP 30 mg
International Trade Name: Prevacid® (ODT)

Lanzol Junior 30 is a high-quality Lansoprazole 30 mg orally disintegrating tablet, a reliable generic equivalent of the internationally recognized proton pump inhibitor (PPI) marketed under the brand name Prevacid®. Manufactured in WHO-GMP certified facilities, Lanzol Junior ODT is supplied by trusted pharmaceutical exporters from India to support global gastroenterology treatment programs, particularly in acid-related disorders.

Lansoprazole is a potent proton pump inhibitor that works by suppressing gastric acid secretion through irreversible inhibition of the H⁺/K⁺-ATPase enzyme system in gastric parietal cells. Lanzol Junior 30 mg Orally Disintegrating Tablets are primarily indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, peptic ulcer disease, Zollinger–Ellison syndrome, and other hypersecretory conditions. The orally disintegrating formulation ensures rapid dissolution in the mouth without the need for water, making it especially suitable for pediatric, geriatric, and dysphagic patients.

Lanzol Junior 30 Lansoprazole ODT is manufactured under stringent GMP quality standards to ensure consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, moisture-resistant, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, retail pharmacies, government healthcare programs, and international pharmaceutical distributors.

PTH 30 mg Tablets
Composition: Cinacalcet Tablets 30 mg
International Trade Name: Sensipar®

PTH is a high-quality Cinacalcet 30 mg tablet, an oral calcimimetic agent designed to manage disorders associated with elevated parathyroid hormone (PTH) levels. It is a reliable generic equivalent of the internationally recognized brand Sensipar®. Manufactured in WHO-GMP certified facilities, PTH Tablets are supplied by trusted pharmaceutical exporters from India to support global nephrology and endocrinology treatment programs.

Cinacalcet works by enhancing the sensitivity of calcium-sensing receptors on parathyroid glands, thereby reducing the secretion of PTH and helping maintain normal calcium and phosphate balance. PTH 30 mg Tablets are primarily indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis, as well as for the management of hypercalcemia in patients with parathyroid carcinoma.

PTH Cinacalcet Tablets are manufactured under stringent GMP quality standards, ensuring consistent potency, safety, and long-term stability. The tablets are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, dialysis centers, endocrinology clinics, government healthcare programs, and international pharmaceutical distributors.

Targocid 400 mg Injection
Composition: Teicoplanin Injection 400 mg
International Trade Name: Targocid®

Targocid is a high-quality Teicoplanin 400 mg injection, a glycopeptide antibiotic designed for intravenous use in the treatment of serious Gram-positive bacterial infections. It is a reliable generic equivalent of the internationally recognized brand Targocid®. Manufactured in WHO-GMP certified facilities, Targocid Injection is supplied by trusted pharmaceutical exporters from India to support global hospital-based anti-infective treatment programs.

Teicoplanin works by inhibiting bacterial cell wall synthesis, effectively targeting Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and Enterococcus species. Targocid 400 mg Injection is primarily indicated for the treatment of severe infections such as bacteremia, endocarditis, skin and soft tissue infections, bone and joint infections, and respiratory tract infections caused by susceptible organisms, particularly in patients where standard antibiotics are ineffective or contraindicated.

Targocid Teicoplanin Injection is manufactured under stringent GMP quality standards to ensure consistent potency, sterility, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for tertiary care hospitals, intensive care units, government healthcare programs, and international pharmaceutical distributors.

Zepdon 400 mg Tablets
Composition: Raltegravir Tablets IP 400 mg
International Trade Name: Isentress®

Zepdon 400 is a high-quality Raltegravir 400 mg tablet, a reliable generic equivalent of the internationally recognized antiretroviral agent marketed under the brand name Isentress®. Manufactured in WHO-GMP certified facilities, Zepdon Tablets are supplied by trusted pharmaceutical exporters from India to support global HIV/AIDS treatment programs.

Raltegravir is an integrase strand transfer inhibitor (INSTI) that works by blocking the HIV integrase enzyme, preventing viral DNA from integrating into the host genome, and thereby inhibiting viral replication. Zepdon 400 mg Tablets are primarily indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents, in both treatment-naïve and treatment-experienced adult and pediatric patients.

Zepdon 400 Raltegravir Tablets are manufactured under stringent GMP quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, tamper-proof, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, clinics, antiretroviral therapy centers, government HIV programs, and international pharmaceutical distributors.

PALNOCYTRA 0.25 mg/5 ml Injection
Composition: Palonosetron Hydrochloride Injection 0.25 mg/5 ml
International Trade Name: Aloxi®

PALNOCYTRA 0.25 mg/5 ml is a high-quality Palonosetron Hydrochloride Injection, formulated for the effective prevention and control of nausea and vomiting associated with cancer chemotherapy and surgical procedures. It is a therapeutic equivalent of the internationally recognized 5-HT₃ receptor antagonist marketed under the brand name Aloxi®. Manufactured in WHO-GMP certified facilities, PALNOCYTRA Injection is supplied by reliable pharmaceutical exporters from India to support global oncology and perioperative care programs.

Palonosetron is a second-generation, long-acting selective serotonin (5-HT₃) receptor antagonist that works by blocking serotonin receptors both centrally and peripherally, thereby preventing the emetic reflex triggered by chemotherapy or anesthesia. PALNOCYTRA 0.25 mg/5 ml Injection is primarily indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) associated with moderately and highly emetogenic cancer chemotherapy. It is also used for the prevention of post-operative nausea and vomiting (PONV) in appropriate clinical settings.

PALNOCYTRA Injection offers rapid onset, prolonged duration of action, and superior receptor binding affinity, enabling effective symptom control with a single-dose regimen. Its favorable safety profile and reduced risk of QT interval prolongation make it a preferred choice in modern antiemetic therapy protocols.

PALNOCYTRA 0.25 mg/5 ml Palonosetron Hydrochloride Injection is manufactured under stringent GMP and injectable quality standards, ensuring consistent potency, safety, and stability. The product is supplied in secure, sterile, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, surgical units, tertiary care hospitals, government healthcare programs, and international pharmaceutical distributors.